Compound ID | 1315
Class: Fluoroquinolone
| Spectrum of activity: | Gram-negative |
| Details of activity: | Antofloxacin hydrochloride demonstrates clinical and bacteriological efficacies similar to levofloxacin for the treatment of AECB and AP. |
| Institute where first reported: | Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100083, China. |
| Year first mentioned: | 2008 |
| Highest development stage: | Phase 2 |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/24806573 |
| Guide to Pharmacology: | antofloxacin |
| Citations: |
|